A minor (<50%) signet-ring cell component associated with poor prognosis in colorectal cancer patients: A 26-year retrospective study in China

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Tan, Yinuo ^a   Fu, Jianfei ^b   Li, Xiaofen ^a   Yang, Jiao ^a   Jiang, Mengjie ^a   Ding, Kefeng ^a,c,d   Xu, Jinghong ^a   Li, Jun ^a   Yuan, Ying ^a,c,d  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Jinhua Central Hospital   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA; CHINA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCINOUS ADENOCARCINOMA; OVERALL SURVIVAL; PARTIAL MUCINOUS ADENOCARCINOMA; PARTIAL SIGNET RING CELL CARCINOMA; PRIMARY TUMOR; RECTUM TUMOR; RECURRENCE RISK; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; SURVIVAL RATE; ADOLESCENT; CARCINOMA, SIGNET RING CELL; COLORECTAL NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; CHINA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCINS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84925424722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121944     Document Type: Article

References (38)

1. Pande R, Sunga A, Levea C, Wilding GE, Bshara W, Reid M, et al. Significance of signet-ring cells in patients with colorectal cancer. Dis Colon Rectum. 2008; 51(1):50-5. PMID: 18030531
2. Du W, Mah JT, Lee J, Sankila R, Sankaranarayanan R, Chia KS. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Dis Colon Rectum. 2004; 47(1):78-85. PMID: 14719155
3. Suma KS, Nirmala V. Mucinous component in colorectal carcinoma-prognostic significance: a study in a south Indian population. J Surg Oncol. 1992; 51(1):60-4. PMID: 1325577
4. Sasaki S, Masaki T, Umetani N, Futakawa N, Ando H, Muto T. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observations. Jpn J Clin Oncol. 1998; 28 (3):202-6. PMID: 9614444
5. Song W, Wu SJ, He YL, Cai SR, Zhang CH, Zhang XH, et al. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J (Engl). 2009; 122(13):1486-91. PMID: 19719934
6. Bittorf B, Merkel S, Matzel KE, Wein A, Dimmler A, Hohenberger W. Primary signet-ring cell carcinoma of the colorectum. Langenbeck Arch Surg. 2004; 389(3):178-83. PMID: 15188084
7. Hyngstrom JR, Hu CY, Xing Y, You YN, Feig BW, Skibber JM, et al. Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base. Ann Surg Oncol. 2012; 19(9):2814-21. doi: 10.1245/s10434-012-2321-7 PMID: 22476818
8. Lee WS, Chun HK, Lee WY, Yun SH, Cho YB, Yun HR, et al. Treatment outcomes in patients with signet ring cell carcinoma of the colorectum. Am J Surg. 2007; 194(3):294-8. PMID: 17693269
9. Chang DT, Pai RK, Rybicki LA, Dimaio MA, Limaye M, Jayachandran P, et al. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Modern Pathol. 2012; 25(8):1128-39. doi: 10.1038/modpathol.2012.61 PMID: 22481281
10. Gao P, Song YX, Xu YY, Sun Z, Sun JX, Xu HM, et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases. Histopathology. 2013; 63(5):603-15. doi: 10.1111/his.12190 PMID: 23991632
11. Sung CO, Seo JW, Kim KM, Do IG, Kim SW, Park CK. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. Modern Pathol. 2008; 21(12):1533-41. doi: 10.1038/modpathol.2008.170 PMID: 18849918
12. Mizushima T, Nomura M, Fujii M, Akamatsu H, Mizuno H, Tominaga H, et al. Primary colorectal signetring cell carcinoma: Clinicopathological features and postoperative survival. Surg Today. 2010; 40 (3):234-8. doi: 10.1007/s00595-009-4057-y PMID: 20180076
13. Nozoe T, Anai H, Nasu S, Sugimachi K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol. 2000; 75(2):103-7. PMID: 11064389
14. Yamaguchi T, Taniguchi H, Fujita S, Sekine S, Yamamoto S, Akasu T, et al. Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma. Histopathology. 2012; 61(2):162-9. doi: 10.1111/j.1365-2559.2012.04235.x PMID: 22448644
15. Ooi BS, Ho YH, Eu KW, Choen FS. Primary colorectal signet-ring cell carcinoma in Singapore. Anz J Surg. 2001; 71(12):703-6. PMID: 11906382
16. Papadopoulos VN, Michalopoulos A, Netta S, Basdanis G, Paramythiotis D, Zatagias A, et al. Prognostic significance of mucinous component in colorectal carcinoma. Techniques in coloproctology. 2004; 8 Suppl 1:s123-5. PMID: 15655594
17. Psathakis D, Schiedeck THK, Krug F, Oevermann E, Kujath P, Bruch HP. Ordinary colorectal adenocarcinoma vs. primary colorectal signet-ring cell carcinoma - Study matched for age, gender, grade, and stage. Dis Colon Rectum. 1999; 42(12):1618-25. PMID: 10613484
18. Kang HJ, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum. 2005; 48(6):1161-8. PMID: 15868237
19. Chen JX, Tang XD, Xiang DB, Dong XL, Peng FY, Sun GY. TNM Stages and Prognostic Features of Colorectal and Mucinous Adenocarcinoma Patients: a Meta Analysis. Asian Pac J Cancer P. 2012; 13(7):3427-30. PMID: 22994772
20. Gopalan V, Smith RA, Ho YH, Lam AKY. Signet-ring cell carcinoma of colorectum-current perspectives and molecular biology. Int J Colorectal Dis. 2011; 26(2):127-33. doi: 10.1007/s00384-010-1037-z PMID: 20686774
21. Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol. 2000; 73(2):70-4. PMID: 10694641
22. Verhulst J, Ferdinande L, Demetter P, Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012; 65(5):381-8. doi: 10.1136/jclinpath-2011-200340 PMID: 22259177
23. Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB, Ray JE. Mucinous Carcinoma - Just Another Colon Cancer. Dis Colon Rectum. 1993; 36(1):49-54. PMID: 8380140
24. Farhat MH, Barada KA, Tawil AN, Itani DM, Hatoum HA, Shamseddine AI. Effect of mucin production on survival in colorectal cancer: a case-control study. World journal of gastroenterology: WJG. 2008; 14 (45):6981-5. PMID: 19058335
25. th ed. Lyon: International Agency for Research on Cancer; 2010. 417 p. p.
26. Fu JF, Yang J, Tan YN, Jiang MJ, Wen F, Huang YQ, et al. Young Patients (< = 35years old) With Colorectal Cancer Have Worse Outcomes Due to More Advanced Disease. Medicine. 2014; 93(23). doi: 10.1097/MD.0000000000000098 PMID: 25415674
27. Fu JF, Huang YQ, Yang J, Yi CH, Chen HL, Zheng S. Clinical characteristics and prognosis of young patients with colorectal cancer in Eastern China. World journal of gastroenterology: WJG. 2013; 19 (44):8078-84. doi: 10.3748/wjg.v19.i44.8078 PMID: 24307803
28. Halvorsen TB, Seim E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J Clin Pathol. 1988; 41(10):1068-72. PMID: 2848059
29. Mekenkamp LJM, Heesterbeek CJ, Punt CJA, Nagtegaal ID. Reply letter to: Signet ring cell carcinoma as a potential confounding factor in the analysis of outcomes with colorectal mucinous adenocarcinoma. Eur J Cancer. 2012; 48(16):3128-9. doi: 10.1016/j.ejca.2012.08.015 PMID: 22959467
30. Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2006; 19(1):59-68.
31. Maisano R, Azzarello D, Maisano M, Mafodda A, Bottari M, Egitto G, et al. Mucinous histology of colon cancer predicts poor outcomes with FOLFOX regimen in metastatic colon cancer. J Chemotherapy. 2012; 24(4):212-6. doi: 10.1179/1973947812Y.0000000013 PMID: 23040685
32. Kim SH, Shin SJ, Lee KY, Kim H, Kim TI, Kang DR, et al. Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study. Ann Surg Oncol. 2013; 20(11):3407-13. doi: 10.1245/s10434-013-3169-1 PMID: 23943026
33. Langner C, Harbaum L, Pollheimer MJ, Kornprat P, Lindtner RA, Schlemmer A, et al. Mucinous differentiation in colorectal cancer-indicator of poor prognosis? Histopathology. 2012; 60(7):1060-72. doi: 10.1111/j.1365-2559.2011.04155.x PMID: 22348346
34. Negri FV, Wotherspoon A, Cunningham D, Norman AR, Chong G, Ross PJ. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol. 2005; 16(8):1305-10. PMID: 15857840
35. Catalano V, Loupakis F, Graziano F, Torresi U, Bisonni R, Mari D, et al. Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. British journal of cancer. 2009; 100(6):881-7. doi: 10.1038/sj.bjc.6604955 PMID: 19259089
36. Ahn JB, Kim SH, Shin SJ, Lee KY, Kim TI, Hur H, et al. Mucinous histology to predict disease-free survival in microsatellite stable stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy. J Clin Oncol. 2012; 30(15).
37. Catalano V, D'Emidio S, Loupakis F, Graziano F, Torresi U, Mari D, et al. Mucinous histology in advanced colorectal cancer patients treated with first-line irinotecan- and/or oxaliplatin-based chemotherapy. J Clin Oncol. 2008; 26(15).
38. Catalano V, Loupakis F, Bisonni R, Torresi U, Santini D, Silva RR, et al. Impact of mucinous histology on prognosis for patients with radically resected stage Dukes B2 and C colon cancer: Preliminary results. J Clin Oncol. 2009; 27(15).